Argenica Therapeutics Cancels Expiring Options
Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Ltd has announced the cancellation of 205,761 options due to expire on September 30, 2024, as a result of a mutual agreement with the holders. The announcement was made public on Wednesday, June 5, 2024. This move may impact investors holding or considering Argenica Therapeutics in their portfolios.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.